Tomasz Adamus

607 total citations
12 papers, 451 citations indexed

About

Tomasz Adamus is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tomasz Adamus has authored 12 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tomasz Adamus's work include RNA Interference and Gene Delivery (4 papers), Sarcoma Diagnosis and Treatment (2 papers) and CAR-T cell therapy research (2 papers). Tomasz Adamus is often cited by papers focused on RNA Interference and Gene Delivery (4 papers), Sarcoma Diagnosis and Treatment (2 papers) and CAR-T cell therapy research (2 papers). Tomasz Adamus collaborates with scholars based in United States, Poland and Singapore. Tomasz Adamus's co-authors include Marcin Kortylewski, Piotr Swiderski, Dayson Moreira, Zhuoran Zhang, Stephen J. Forman, Marcin Majka, Klaudia Skrzypek, Xingli Zhao, Yu‐Lin Su and Guido Marcucci and has published in prestigious journals such as Nucleic Acids Research, Blood and Oncogene.

In The Last Decade

Tomasz Adamus

12 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomasz Adamus United States 9 248 140 134 127 55 12 451
Pradeep Chaluvally–Raghavan United States 12 344 1.4× 117 0.8× 236 1.8× 133 1.0× 61 1.1× 24 520
Anxo Martínez-Ordóñez Spain 10 180 0.7× 111 0.8× 144 1.1× 193 1.5× 50 0.9× 15 434
Priya Chatterji United States 11 348 1.4× 165 1.2× 195 1.5× 209 1.6× 23 0.4× 16 590
Carmen M. Anadon United States 10 334 1.3× 187 1.3× 141 1.1× 195 1.5× 48 0.9× 18 634
Bart Krist Poland 9 217 0.9× 123 0.9× 119 0.9× 79 0.6× 31 0.6× 11 434
Adilson Fonseca Teixeira Australia 7 294 1.2× 107 0.8× 161 1.2× 166 1.3× 63 1.1× 17 486
Justin Wang United States 9 206 0.8× 122 0.9× 87 0.6× 144 1.1× 45 0.8× 12 430
Maria A. Voronkova United States 9 280 1.1× 91 0.7× 114 0.9× 119 0.9× 56 1.0× 15 452
Thu Le Trinh United States 11 205 0.8× 135 1.0× 64 0.5× 95 0.7× 27 0.5× 20 425

Countries citing papers authored by Tomasz Adamus

Since Specialization
Citations

This map shows the geographic impact of Tomasz Adamus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Adamus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Adamus more than expected).

Fields of papers citing papers by Tomasz Adamus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomasz Adamus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Adamus. The network helps show where Tomasz Adamus may publish in the future.

Co-authorship network of co-authors of Tomasz Adamus

This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Adamus. A scholar is included among the top collaborators of Tomasz Adamus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Adamus. Tomasz Adamus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Adamus, Tomasz, et al.. (2023). Impact of AMPK on cervical carcinoma progression and metastasis. Cell Death and Disease. 14(1). 43–43. 6 indexed citations
2.
Adamus, Tomasz, Elaine Kang, Mohamed Hammad, et al.. (2021). Glioma-targeted delivery of exosome-encapsulated antisense oligonucleotides using neural stem cells. Molecular Therapy — Nucleic Acids. 27. 611–620. 64 indexed citations
3.
Su, Yu‐Lin, Xiuli Wang, Mati Mann, et al.. (2019). Myeloid cell–targeted miR-146a mimic inhibits NF-κB–driven inflammation and leukemia progression in vivo. Blood. 135(3). 167–180. 97 indexed citations
4.
Herrmann, Andreas, Christoph Lahtz, Jieun Song, et al.. (2019). Integrin α6 signaling induces STAT3-TET3-mediated hydroxymethylation of genes critical for maintenance of glioma stem cells. Oncogene. 39(10). 2156–2169. 32 indexed citations
5.
Skrzypek, Klaudia, et al.. (2018). SNAIL is a key regulator of alveolar rhabdomyosarcoma tumor growth and differentiation through repression of MYF5 and MYOD function. Cell Death and Disease. 9(6). 26 indexed citations
6.
Moreira, Dayson, Tomasz Adamus, Xingli Zhao, et al.. (2018). STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers. Clinical Cancer Research. 24(23). 5948–5962. 64 indexed citations
7.
Adamus, Tomasz & Marcin Kortylewski. (2018). The revival of CpG oligonucleotide-based cancer immunotherapies. Współczesna Onkologia. 2018(1). 56–60. 85 indexed citations
8.
9.
Zhao, Xingli, Zhuoran Zhang, Dayson Moreira, et al.. (2018). B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors. Molecular Therapy. 26(3). 695–707. 26 indexed citations
10.
Hoinka, Jan, et al.. (2018). AptaBlocks: Designing RNA complexes and accelerating RNA-based drug delivery systems. Nucleic Acids Research. 46(16). 8133–8142. 7 indexed citations
11.
Skrzypek, Klaudia, et al.. (2015). Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression. Oncotarget. 6(31). 31378–31398. 28 indexed citations
12.
Adamus, Tomasz, et al.. (2014). The strategy of fusion genes construction determines efficient expression of introduced transcription factors.. Acta Biochimica Polonica. 61(4). 773–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026